DIVAMICS

Our Expertise in Drug
Discovery

We specialize in accelerating the early stages of drug discovery, from hit identification to preclinical candidate (Hits-to-PCC).
Leveraging years of cross-disciplinary expertise, we apply our AI-driven and molecular
dynamics-based technologies across four key therapeutic modalities — each with
proven precision and efficiency.

Therapeutic Areas
We Excel In

Strategic Approaches to
Maximize Discovery Value

"First-in-Class"
Discovery

We accelerate the development of innovative new therapies for unmet medical needs.

"Me-Better"
Optimization

We optimize existing clinical drugs to create improved versions with enhanced properties.

Allosteric Drug
Development

We pioneer the research and development of allosteric drugs based on novel structural mechanisms.

Dual-target
Agonist

We optimize the agonist's sequence to enhance its activity to 2-3 times that of existing comparable drugs.

Ready to accelerate your next breakthrough?

Contact our team to discuss your specific target, modality, or discovery challenge.

Our Expertise in Drug Discovery

Strategic Approaches to Maximize Discovery Value

Ready to accelerate your next breakthrough?

Our Expertise in Drug
Discovery

Strategic Approaches to
Maximize Discovery Value